By Mill Chart
Last update: Oct 20, 2023
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted SHOCKWAVE MEDICAL INC showing up in our growth with base formation screen, so it may be worth spending some more time on it.
A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:SWAV has received a 8 out of 10:
ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:SWAV scores a 8 out of 10:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:SWAV, the assigned 6 is a significant indicator of profitability:
In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the level of consolidation in the stock based on multiple short-term technical indicators. Currently, NASDAQ:SWAV has a 8 as its setup rating, indicating its current consolidation status.
Although the technical rating is bad, SWAV does present a nice setup opportunity. Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at 210.93. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 185.88, a Stop Loss order could be placed below this zone.
More Strong Growth stocks can be found in our Strong Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of SWAV
Check the latest full technical report of SWAV for a complete technical analysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
SHOCKWAVE MEDICAL INC
NASDAQ:SWAV (4/18/2024, 7:22:16 PM)
After market: 327.52 0 (0%)327.52
+0.02 (+0.01%)
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.
Is SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) on the Verge of a Major Breakout as a Strong Growth Stock?
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.
These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.
The company is hoping to expand, but is there enough here to attract growth investors?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina